Direxion Daily S&P Biotech Bear 3X Shares
LABD
LABD
18 hedge funds and large institutions have $8.35M invested in Direxion Daily S&P Biotech Bear 3X Shares in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
76% less capital invested
Capital invested by funds: $35.5M → $8.35M (-$27.1M)
Holders
18
Holding in Top 10
–
Calls
$17.8M
Puts
$5.47M
Top Buyers
| 1 | +$1.84M | |
| 2 | +$1.25M | |
| 3 | +$986K | |
| 4 |
CG
Cutler Group
San Francisco,
California
|
+$405K |
| 5 |
FTUS
Flow Traders U.S.
New York
|
+$401K |
Top Sellers
| 1 | -$27.2M | |
| 2 | -$2.26M | |
| 3 | -$1.3M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$816K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$177K |